drug protocol number

NN7535-7807

drug sponsor

Novo Nordisk

drug study

Etavopivat

drug trial site

King Abdulaziz Hospital NG (Al Ahsa), King Faisal Specialist Hospital and Research Center (Riyadh) ,Imam Abdulrahman Al Faisal Hospital NG (Dammam)

drug status

Ongoing

drug phase